AWM
Avior Wealth Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,195
| Closed | -$101K | – | 761 |
|
|
2025
Q1 | $101K | Hold |
15,195
| – | – | ﹤0.01% | 697 |
|
|
2024
Q4 | $191K | Sell |
15,195
-1,304
| -8% | -$16.4K | 0.01% | 713 |
|
|
2024
Q3 | $305K | Buy |
16,499
+473
| +3% | +$8.74K | 0.01% | 584 |
|
|
2024
Q2 | $345K | Buy |
16,026
+1,259
| +9% | +$27.1K | 0.01% | 531 |
|
|
2024
Q1 | $398K | Sell |
14,767
-1,330
| -8% | -$35.8K | 0.02% | 512 |
|
|
2023
Q4 | $482K | Sell |
16,097
-1,670
| -9% | -$50.1K | 0.03% | 357 |
|
|
2023
Q3 | $364K | Buy |
17,767
+1,487
| +9% | +$30.5K | 0.02% | 404 |
|
|
2023
Q2 | $323K | Sell |
16,280
-894
| -5% | -$17.8K | 0.02% | 435 |
|
|
2023
Q1 | $294K | Buy |
17,174
+2,269
| +15% | +$38.9K | 0.02% | 455 |
|
|
2022
Q4 | $292K | Buy |
14,905
+1,114
| +8% | +$21.8K | 0.02% | 406 |
|
|
2022
Q3 | $220K | Buy |
13,791
+405
| +3% | +$6.46K | 0.02% | 438 |
|
|
2022
Q2 | $184K | Buy |
13,386
+5,328
| +66% | +$73.2K | 0.02% | 430 |
|
|
2022
Q1 | $127K | Sell |
8,058
-1,233
| -13% | -$19.4K | 0.01% | 480 |
|
|
2021
Q4 | $202K | Buy |
9,291
+714
| +8% | +$15.5K | 0.02% | 429 |
|
|
2021
Q3 | $256K | Hold |
8,577
| – | – | 0.02% | 397 |
|
|
2021
Q2 | $379K | Buy |
8,577
+49
| +0.6% | +$2.17K | 0.04% | 338 |
|
|
2021
Q1 | $378K | Sell |
8,528
-35
| -0.4% | -$1.55K | 0.04% | 330 |
|
|
2020
Q4 | $469K | Sell |
8,563
-1,767
| -17% | -$96.8K | 0.06% | 283 |
|
|
2020
Q3 | $236K | Sell |
10,330
-1,330
| -11% | -$30.4K | 0.03% | 359 |
|
|
2020
Q2 | $244K | Buy |
11,660
+1,450
| +14% | +$30.3K | 0.04% | 360 |
|
|
2020
Q1 | $142K | Buy |
10,210
+2,210
| +28% | +$30.7K | 0.03% | 388 |
|
|
2019
Q4 | $182K | Sell |
8,000
-150
| -2% | -$3.41K | 0.03% | 383 |
|
|
2019
Q3 | $94K | Buy |
8,150
+2,390
| +41% | +$27.6K | 0.02% | 414 |
|
|
2019
Q2 | $86K | Buy |
+5,760
| New | +$86K | 0.02% | 421 |
|